An Open-label, Phase II, Dose-finding Study of Three Dose Strengths of MR-130A-01 Contraceptive Transdermal Patch in Healthy Pre-menopausal Women
Latest Information Update: 02 Dec 2024
At a glance
- Drugs Norelgestromin (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Viatris
Most Recent Events
- 09 May 2024 New trial record